Annual report pursuant to Section 13 and 15(d)

BUSINESS (Details Narrative)

v3.22.1
BUSINESS (Details Narrative)
Jul. 28, 2016
BioCorRx Pharmaceuticals [Member]  
Equity issued ownership 75.80%
BioCorRx Pharmaceuticals, Inc [Member]  
management fee 65.00%
Non-Controlling Interest [Member]  
Equity issued ownership 24.20%